In the agIng population, osteoporosis is an important public health problem worldwide due to its high morbidity and mortality. Also, metabolic syndrome (MS) is another very common medical problem of epidemic importance, and the number of patients with MS is rapidly increasing in industrialized countries.
increases with increasing components of MS [1] . On the other hand, men with MS had a lower BMD after adjustment for body mass index (BMI) in the Rancho Bernardo Study [2] and women with MS also have a lower BMD in a recent study [3] . A prospective study has also demonstrated that men with MS had a lower BMD at the hip, whole body and distal forearm [4] .
MS is characterized by abdominal obesity, impaired glucose tolerance, hypertension and dyslipidemia [5] . MS is a cluster of conditions with detrimental effects on cardiovascular health and has a strong association with low grade inflammation [6] . Obesity or high BMI is known to be a protecting factor against excessive bone loss in aging [7] [8] [9] [10] . However, inflammation is more severe in subjects with high insulin resistance than in those with low insulin resistance [11, 12] , even-circumference at the bending point was measured in centimeters with the participant wearing only a single layer of clothes. Blood pressure was measured in millimeters of mercury (mmHg) using an aneuroid sphygmomanometer and was taken as the mean of 2 consecutive measurements after at least 5 minutes of sitting. Postmenopausal status was defined, through a close history taking, as cessation of menstruation for at least 1 year. A fasting blood specimen was drawn from each subject. Automated hsCRP measurements were performed with immunoturbidimetry with a Modular clinical analyzer (Roche, Basel, Switzerland). The declared detection limits were 0.03mg/dL. Lipid profile was determined with homogenous enzymatic colorimetric assay (Modular, Roche, Switzerland). The study was approved by the Institutional Review Board of Pusan University Hospital, Pusan, Korea.
Metabolic syndrome
MS was defined according to the American Heart Association/National Heart, Lung and Blood Institute (AHA/NHLBI) report. Abdominal obesity was redefined on the basis of an Asian-specific cutoff point in criteria.
Subjects were considered as MS if they had 3 or more of the following abnormalities: abdominal obesity (waist circumference ≥ 90 cm for men and ≥ 80 cm for women), hypertriglyceridemia ≥ 150 mg/dL (1.7 mmol/L), low HDL cholesterol (< 40 mg/dL [1.0 mmol/L] for men and < 50 [1.3 mmol/L] for women) or use of antihypertensive agent, and high fasting glucose (≥ 100 mg/dL [5.6 mmol/L]) or use of hypoglycemic agents (e.g., insulin or an oral agent) [19] .
BMD measurements
The BMD of the lumbar spine and femoral neck was measured by dual energy X-ray absorptiometry using a Lunar Prodigy (GE Medical, Madison, WI, USA) calibrated daily using a standard phantom provided by the manufacturer. Lumbar spine BMD was the mean of lumbar vertebrae 1-4.
Statistical Analysis
The baseline characteristics of subjects with MS and controls were compared by the Student's t test for continuous variables, and by the χ 2 test for categorical variables. Analysis of covariance (ANCOVA) was used to compare the BMD levels of those with and without MS after adjusting for covariates including age, BMI, tually resulting in a reduced BMD.
Osteoporosis is a skeletal disorder characterized by compromised bone strength that predisposes affected persons to an increased risk of fracture [13] . Some studies have suggested that osteoporosis is linked to inflammation [14, 15] . Proinflammatory cytokines up-regulate receptor activators of nuclear factor-κB ligand, leading to increased bone resorption and osteoporosis [16] [17] [18] .
Similarly, MS has both conflicting factors of osteoporosis; one with a protective property -obesity and another one which can activate bone resoptioninflammation. This can be the reason for the inconsistent results in the relationship between MS and BMD. The aim of this study was to evaluate the difference in BMD between women with MS and those without in pre-and post-menopausal women. In addition, we performed a stepwise multiple linear regression analysis to estimate which components of MS have a dominant effect on BMD and whether C-reactive protein (CRP) influence BMD.
Materials and Methods

Study subjects
We studied 2,703 women aged ≥ 45 years whose BMD was measured at the Health Promotion Center at Pusan University Hospital between January 2006 and December 2009. Five hundred thirty-eight women with a history of the following conditions were exclude from the study: those taking medication for osteoporosis (n=2), diabetes (n=69), hypertension (n=145) or hypercholesterolemia (n=118); those receiving hormone replacement therapy or other medications, such as glucocorticoid and vitamin D, affecting BMD (n=21); those with conditions, such as malignancy, thyroid disease or thyroid functional abnormality, that would be apparent causes for abnormal bone mass (n=163); those who had a limited physical activity from a stroke or dementia; and those with acute infectious disease or chronic inflammatory diseases (n=20). A total of 2,165 women were analyzed. Each subject was asked to complete a questionnaire to determine their smoking habits (current, past or never), alcohol intake (units per week), physical exercise (the number of times per week), medication history and history of previous medical or surgical disease.
All subjects underwent a structured medical interview and a thorough medical examination. BMI was calculated from body weight and height (kg/m 2 ). Waist and 13.5% in the postmenopausal group. The baseline characteristics of subjects are presented in Table 1 .
In the 2 groups, women with MS were older and had greater values of weight, BMI, waist circumference, blood pressure, serum concentration of fasting glucose/triglycerides, uric acid, HOMA-IR, fat mass and lean mass, while they had a lower serum HDL cholesterol concentration. In the postmenopausal group, CRP was significantly higher in subjects with MS than those without, but it was not significantly different in the premenopausal group (p=0.009 and p=0.396, respectively). Table 2 shows the results of statistical analyses alcohol intake, cigarette smoking and exercise. A stepwise multiple linear regression analysis was used to identify independent predictors of BMD of the lumbar spine and femoral neck in the pre-and postmenopausal groups. All statistical analyses were performed with SPSS for the Windows Statistical Package Version 12.0 (SPSS Inc, Chicago, IL., USA). P value of <0.05 was considered significant.
Results
Among 2,165 women, 194 (9%) had MS. The prevalence of MS was 5.5% in the premenopausal group to metabolic states, we performed a stepwise multiple linear regression analysis in each group. As independent variables, we put in systolic blood pressure(SBP), diastolic blood pressure (DBP), triglyceride, HDL cholesterol, glucose, waist circumference and CRP. The relationship between BMD and the parameters of MS including CRP was established by the stepwise linear regression analysis, as shown in Table 3 . In this model, significant predictive factors for the BMD of the lumbar spine were SBP in the premenopausal group and HDL-cholesterol and DBP in the postmenopausal group. On the other hand significant predictive factors of covariates with adjusted mean BMD at each bone site in pre-and postmenopausal women with or without MS. In the postmenopausal group, women with MS had a lower BMD at the lumbar spine and femoral neck. These differences remained after adjusting for age, height, weight, and all covariates (alcohol intake, smoking and exercise). In the premenopausal group, women with MS had a lower BMD at the lumbar spine, but not at the femoral neck either before or after adjustment for age and covariates.
To identify the independent factors affecting the BMD of the lumbar spine and femoral neck according 0.001 CRP = C-reactive protein; SBP = systolic blood pressure; DBP = diastolic blood pressure; WC = waist circumference; HDL-cholesterol = high density lipoprotein cholesterol, ß = standardized regression coefficient, t=corresponding t values, R 2 = percent variance explained by each variable Stepwise variable inclusion with p < 0.05 and exclusion with p > 0. 10 in the premenopausal group, and HDL cholesterol and DBP in the postmenopausal group. This result was consistent with those of studies that have shown that HDL-C positively correlates with BMD in the lumbar spine in postmenopausal women [24, 25] . In our study, the independent variables affecting the BMD of the femoral neck were waist circumference and DBP in the premenopausal group and CRP and DBP in the postmenopausal group. This may also explain why the BMD of the femur was not lower in women with MS than in those without in the premenopausal group. The protective effect of obesity might significantly affect the BMD of the femur in the premenopausal group. It is well known that a higher BMI is associated with a slower rate of bone loss. CRP and DBP were associated with the BMD of the femoral neck in the postmenopausal group. In several studies, it has been reported the inverse relationship between bold pressure and bone state. Some of them reported independent marker of bone loss as SBP [26, 27] , and the others did as DBP [28] . Likewise these articles, SBP and DBP were related with low BMD in our study. The exact reason for this is unclear. Some report that hypertension is related with low bone mass due to the changes of serum intact PTH concentration [29] or urinary calcium excretion [30, 31] . But the results are inconsistent. The CRP, a representative marker for inflammation, is a main factor for the BMD of the femur in the postmenopausal women. The MS has been known as a low-grade inflammatory state. CRP may represent the patient's status of inflammation. In the postmenopausal women, CRP is more associated with the BMD of the femur than obesity. It could be the reason why the BMD of the femur was lower in subjects with MS than in those without. Many studies have shown that inflammatory cytokines play an important role in osteoclastic bone resorption and in the pathogenesis of osteoporosis. The production of IL-1, IL-6 and/or TNF-a correlates positively with bone loss in healthy premenopausal and/or postmenopausal women. Besides, some studies reported that high sensitive CRP is related to incidence of fractures in clinical setting [32, 33] . Thus, it is apparent that low-grade inflammation in MS patients is associated with bone loss despite the protective effects of general obesity.
There are several limitations to this study. First, The subjects were enrolled in single center , cross-sectional design. So, there is limitation that the subject does not represent general female population. Like other crossfor the BMD of the femoral neck were DBP and waist circumference in the premenopausal group and DBP and CRP in the postmenopausal group.
Discussion
According to our study, MS had negative correlations with the BMD of the lumbar spine and femoral neck in the postmenopausal group and with the BMD of the lumbar spine in the premenopausal group. After adjustment of age or other covariates, the negative relationship was still remained. The independent factors for the BMD of the femoral neck were waist circumference and DBP in the premenopausal group, and CRP and DBP in the postmenopausal group. To our knowledge, this is the first study to examine the association of the components of MS including CRP and the BMD in pre-and postmenopausal women.
The prevalence of MS who met the AHA/NHLBI criteria was reported to be about 20%-23% in other studies [20, 21] . In our study, 194 (9%) of 2,165 women had MS. This prevalence was lower than those of other studies. This may be because we excluded the patients that already known to have diabetes mellitus, hypertension or endocrine diseases who had taken medications that may have affected bone metabolism.
According to our results, subjects with MS had a significantly lower BMD of the lumbar spine and femoral neck before and after adjustment for age and all covariates in the postmenopausal group. Meanwhile, in the premenopausal group, women with MS had a significantly lower BMD of the lumbar spine, but not of the femoral neck before and after adjustment for age and all covariates. In the premenopausal group, there was no significant difference in the BMD of femoral neck between subjects with MS and without MS. The reason for this may be that a decrease in the BMD of the femoral neck is slower than that of the lumbar spine during premenopause or early postmenopause [22] . This may be attributed to the protective effect of estrogen on bone. In addition, the onset of estrogen deficiency in women is associated with rapid bone loss, particularly in trabecular bone as in the vertebrae [23] . Cortical bone, as in the long bones, also decreases due to estrogen deficiency, but at a slow rate. In the postmenopausal group, the BMD of the lumbar spine and femoral neck was lower in subjects with MS than in those without. In a stepwise multiple regression analysis, the BMD of the lumbar spine was affected by SBP lumbar spine was lower in those with MS than in those without.
In conclusion, among variable factors of MS, inflammation might play a more important role in bone metabolism, especially in postmenopausal women.
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sectional studies, it is also difficult to determine the cause and effect of MS with respect to BMD. Second, we did not check the level of serum, estradiol, folliclestimulating hormone, intact PTH, 25 (OH) D, markers of bone turnover and 24 hr urine calcium levels, which might affect BMD. Third, we did not collect the information about fractures.
The associations between individual components of MS and low BMD have been extensively studied, but the results are inconclusive. That is because of the characteristics of MS including both obesity and inflammation. In our study, MS had a negative correlation with the BMD of the lumbar and femoral neck in the postmenopausal group. The BMD of the femoral neck was similar between those with and without MS in the premenopausal group, and the BMD of the
